###begin article-title 0
###xml 131 137 131 132 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fn1" ref-type="fn">&#8224;</xref>
Cooperative Regulation of the Activity of Factor Xa within Prothrombinase by Discrete Amino Acid Regions from Factor Va Heavy Chaindagger
###end article-title 0
###begin p 1
This work was supported by R01 Grant HL-73343 from the National Heart, Lung and Blood Institute (to M.K.), by Computational Grant PFS0202 from the Ohio Supercomputer Center (to M.K.), by National Science Foundation Computational Grant MCB060021T under the NSF programs Partnerships for Advanced Computational Infrastructure Distributed Terascale Facility and Terascale Extensions: Enhancement to the Extensible Terascale Facility (to M.K.), and Predoctoral Fellowship 0715435B from the American Heart Association Ohio Valley Affiliate (to M. A. Bukys).
###end p 1
###begin p 2
Cleveland State University.
###end p 2
###begin p 3
Present address: The Hamner Institutes for Health Sciences, Six Davis Drive, Research Triangle Park, NC 27709.
###end p 3
###begin p 4
Cleveland Clinic.
###end p 4
###begin p 5
###xml 180 199 180 199 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="http://pubs.acs.org">http://pubs.acs.org</uri>
This is an open-access article distributed under the ACS AuthorChoice Terms & Conditions. Any use of this article, must conform to the terms of that license which are available at http://pubs.acs.org.
###end p 5
###begin p 6
40.75
###end p 6
###begin p 7
###xml 0 0 0 0 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="bi-2008-01241r_0007" id="tgr1"/>

###end p 7
###begin p 8
###xml 136 139 132 135 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sup>
###xml 143 146 139 142 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">698</sup>
###xml 254 257 250 253 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">271</sup>
###xml 335 338 331 334 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 340 343 336 339 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 601 603 597 599 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 605 608 601 604 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 610 613 606 609 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 625 628 619 622 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sup>
###xml 632 635 626 629 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">698</sup>
###xml 655 660 647 652 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF/4A</sup>
###xml 662 665 654 657 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 667 670 659 662 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 682 685 672 675 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sup>
###xml 689 692 679 682 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">698</sup>
###xml 716 718 704 706 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">6A</sup>
###xml 720 723 708 711 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 725 728 713 716 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 740 743 726 729 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sup>
###xml 747 750 733 736 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">698</sup>
###xml 850 852 834 836 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 863 868 847 852 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">K4/4A</sup>
###xml 883 885 867 869 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">6A</sup>
###xml 988 990 972 974 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt</sup>
###xml 1076 1078 1060 1062 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 1229 1231 1213 1215 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt</sup>
###xml 1307 1312 1291 1296 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF/4A</sup>
###xml 1326 1328 1310 1312 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">6A</sup>
The prothrombinase complex catalyzes the activation of prothrombin to alpha-thrombin. We have repetitively shown that amino acid region 695DYDY698 from the COOH terminus of the heavy chain of factor Va regulates the rate of cleavage of prothrombin at Arg271 by prothrombinase. We have also recently demonstrated that amino acid region 334DY335 is required for the optimal activity of prothrombinase. To assess the effect of these six amino acid residues on cofactor activity, we created recombinant factor Va molecules combining mutations at amino acid regions 334-335 and 695-698 as follows: factor V3K (334DY335 --> KF and 695DYDY698 --> KFKF), factor VKF/4A (334DY335 --> KF and 695DYDY698 --> AAAA), and factor V6A (334DY335 --> AA and 695DYDY698 --> AAAA). The recombinant factor V molecules were expressed and purified to homogeneity. Factor Va3K, factor VaK4/4A, and factor Va6A had reduced affinity for factor Xa, when compared to the affinity of the wild-type molecule (factor VaWt) for the enzyme. Prothrombinase assembled with saturating concentrations of factor Va3K had a 6-fold reduced second-order rate constant for prothrombin activation compared to the value obtained with prothrombinase assembled with factor VaWt, while prothrombinase assembled with saturating concentrations of factor VaKF/4A and factor Va6A had approximately 1.5-fold reduced second-order rate constants. Overall, the data demonstrate that amino acid region 334-335 together with amino acid region 695-698 from factor Va heavy chain are part of a cooperative mechanism within prothrombinase regulating cleavage and activation of prothrombin by factor Xa.
###end p 8
###begin p 9
###xml 146 147 142 143 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref1">1</xref>
###xml 324 325 320 321 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref1">1</xref>
###xml 326 327 322 323 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref2">2</xref>
###xml 755 756 747 748 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 756 757 748 749 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 790 791 782 783 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 791 794 783 786 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 872 873 864 865 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 873 874 865 866 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 1057 1058 1049 1050 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 1058 1061 1050 1053 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 1158 1159 1150 1151 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref3">3</xref>
###xml 1160 1161 1152 1153 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref5">5</xref>
###xml 1437 1438 1429 1430 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref6">6</xref>
###xml 1439 1441 1431 1433 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref11">11</xref>
###xml 1582 1585 1570 1573 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">709</sup>
###xml 1590 1594 1578 1582 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">1018</sup>
###xml 1603 1607 1591 1595 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">1545</sup>
###xml 1660 1661 1648 1649 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 1661 1662 1649 1650 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">r</sub>
###xml 1723 1724 1699 1700 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 1724 1725 1700 1701 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">r</sub>
###xml 1811 1813 1775 1777 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref12">12</xref>
###xml 1814 1816 1778 1780 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref15">15</xref>
###xml 1826 1827 1790 1791 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">1</xref>
###xml 1938 1940 1902 1904 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref16">16</xref>
###xml 1941 1943 1905 1907 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref17">17</xref>
###xml 2202 2205 2166 2169 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">271</sup>
###xml 2225 2227 2189 2191 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref18">18</xref>
###xml 2228 2230 2192 2194 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref21">21</xref>
###xml 2452 2454 2412 2414 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref22">22</xref>
###xml 2619 2621 2579 2581 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
###xml 1444 1449 <span type="species:ncbi:9606">Human</span>
alpha-Thrombin is required for survival and is formed following activation of its inactive precursor, prothrombin, by the prothrombinase complex (1). The prothrombinase complex is composed of the enzyme, factor Xa, and the protein cofactor, factor Va, assembled on a membrane surface in the presence of divalent metal ions (1,2). Even though factor Xa alone can activate prothrombin, the rate of this reaction is not compatible with survival. Incorporation of factor Va into the prothrombinase complex increases the catalytic efficiency of prothrombin activation by 5 orders of magnitude, thus providing the physiological pathway for alpha-thrombin production. This increase in the efficiency of prothrombinase is the result of a 100-fold decrease in the Km and a 3000-fold increase in the kcat of prothrombinase compared to those for factor Xa alone. The decrease in the Km is the result of a tighter interaction of the prothrombinase complex with the membrane surface, which results in higher local concentrations of the enzyme, while the increase in the kcat of the enzyme is credited solely to the productive interaction between factor Va and factor Xa (3-5). While the exact molecular mechanism by which factor Va exerts its cofactor function is still under investigation, it has been well established that the productive interaction of the heavy chain of factor Va with prothrombin involves anion binding exosite I of prothrombin (6-11). Human factor V circulates in plasma as a single-chain inactive precursor. Proteolytic cleavage of the procofactor by alpha-thrombin at Arg709, Arg1018, and Arg1545 produces a heterodimer consisting of a heavy chain (Mr approximately 105000; A1 and A2 domains) and a light chain (Mr approximately 74000; A3, C1, and C2 domains) associated through divalent metal ions (12-15) (Figure 1). We have demonstrated that a binding site for factor Xa is contained within the heavy chain of the cofactor (16,17), and we have established that the COOH terminus of the factor Va heavy chain (amino acids 680-709) is essential for optimal expression of cofactor activity because it promotes a productive interaction with prothrombin, regulating the rate of cleavage at Arg271 by prothrombinase (18-21). This region of the cofactor is highly acidic in nature and contains several tyrosine residues that have been shown to have potential to be involved in factor V activation by alpha-thrombin and proper cofactor function (22). We have also recently shown that residues from the central portion of the heavy chain of factor Va (amino acid region 334-335) are crucial for cofactor function (23). This study was undertaken to understand the importance of these two spatially distinct, important regions of factor Va heavy chain when acting in concert on prothrombinase complex assembly and function.
###end p 9
###begin p 10
###xml 210 213 206 209 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">709</sup>
###xml 218 222 214 218 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">1018</sup>
###xml 231 235 227 231 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">1545</sup>
###xml 402 404 398 400 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
###xml 564 566 560 562 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref20">20</xref>
###xml 567 569 563 565 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref21">21</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human factor V structure. Factor V is composed of 2196 amino acids with three A domains, a connecting B region, and two C domains. The procofactor is activated following three cleavages by alpha-thrombin at Arg709, Arg1018, and Arg1545. The mutations within a 13-amino acid region of the A2 domain of the heavy chain of the molecule that is crucial for cofactor activity (amino acid residues 323-335) (23) and within the acidic hirudin-like COOH-terminal region of the heavy chain (amino acid residues 680-709) required for the optimal function of prothrombinase (20,21) are indicated together with the designation of the recombinant mutant factor V molecules created and used throughout this work. Residues DY from both regions that are mutated in this study are bold and underlined.
###end p 10
###begin title 11
Experimental Procedures
###end title 11
###begin title 12
Materials and Reagents
###end title 12
###begin p 13
###xml 35 36 35 36 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 77 78 77 78 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 106 107 106 107 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 456 457 456 457 <sc xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 487 488 483 484 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fn3" ref-type="fn">1</xref>
###xml 493 494 489 490 <sc xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 601 602 593 594 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 923 924 915 916 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 1468 1470 1452 1454 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">HC</sub>
###xml 1485 1487 1465 1467 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">LC</sub>
###xml 1642 1643 1618 1619 <label xmlns:mml="http://www.w3.org/1998/Math/MathML">1</label>
###xml 1662 1663 1638 1639 <sc xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 1694 1695 1666 1667 <sc xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 1918 1920 1886 1888 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt</sup>
###xml 1970 1972 1938 1940 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 2012 2015 1980 1983 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 2027 2030 1993 1996 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 2057 2059 2021 2023 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 2099 2102 2063 2066 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 2114 2117 2076 2079 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 2143 2147 2103 2107 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KFKF</sup>
###xml 2185 2188 2145 2148 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sup>
###xml 2192 2195 2152 2155 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">698</sup>
###xml 2223 2225 2181 2183 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">4A</sup>
###xml 2263 2266 2221 2224 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sup>
###xml 2270 2273 2228 2231 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">698</sup>
###xml 2302 2304 2258 2260 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 2344 2347 2300 2303 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 2356 2359 2310 2313 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 2368 2371 2320 2323 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sup>
###xml 2380 2383 2330 2333 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">696</sup>
###xml 2392 2395 2340 2343 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">697</sup>
###xml 2408 2411 2354 2357 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">698</sup>
###xml 2438 2440 2382 2384 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">6A</sup>
###xml 2480 2483 2424 2427 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 2492 2495 2434 2437 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 2504 2507 2444 2447 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sup>
###xml 2516 2519 2454 2457 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">696</sup>
###xml 2528 2531 2464 2467 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">697</sup>
###xml 2544 2547 2478 2481 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">698</sup>
###xml 2573 2578 2505 2510 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF/4A</sup>
###xml 2618 2621 2550 2553 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 2630 2633 2560 2563 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 2642 2645 2570 2573 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sup>
###xml 2654 2657 2580 2583 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">696</sup>
###xml 2666 2669 2590 2593 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">697</sup>
###xml 2682 2685 2604 2607 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">698</sup>
###xml 1643 2702 1619 2622 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="14">Abbreviations: PS, <sc>l</sc>-&#945;-phosphatidylserine; PC, <sc>l</sc>-&#945;-phosphatidylcholine; PCPS, small unilamellar phospholipid vesicles composed of 75% PC and 25% PS (w/w); SDS-PAGE, sodium dodecyl sulfate&#8722;polyacryl-amide gel electrophoresis; PVDF, polyvinylidene difluoride; factor Va<sup>Wt</sup>, recombinant human wild-type factor Va; factor Va<sup>KF</sup>, recombinant human factor Va with the D<sup>334</sup> &#8594; K and Y<sup>335</sup> &#8594; F mutations; factor Va<sup>AA</sup>, recombinant human factor Va with the D<sup>334</sup> &#8594; A and Y<sup>335</sup> &#8594; A mutations; factor V<sup>KFKF</sup>, recombinant human factor V with the <sup>695</sup>DYDY<sup>698</sup> &#8594; KFKF mutation; factor V<sup>4A</sup>, recombinant human factor V with the <sup>695</sup>DYDY<sup>698</sup> &#8594; AAAA mutation; factor Va<sup>3K</sup>, recombinant human factor Va with the D<sup>334</sup> &#8594; K, Y<sup>335</sup> &#8594; F, D<sup>695</sup> &#8594; K, Y<sup>696</sup> &#8594; F, D<sup>697</sup> &#8594; K, and Y<sup>698</sup> &#8594; F mutations; factor Va<sup>6A</sup>, recombinant human factor Va with the D<sup>334</sup> &#8594; A, Y<sup>335</sup> &#8594; A, D<sup>695</sup> &#8594; A, Y<sup>696</sup> &#8594; A, D<sup>697</sup> &#8594; A, and Y<sup>698</sup> &#8594; A mutations; factor V<sup>KF/4A</sup>, recombinant human factor Va with the D<sup>334</sup> &#8594; K, Y<sup>335</sup> &#8594; F, D<sup>695</sup> &#8594; A, Y<sup>696</sup> &#8594; A, D<sup>697</sup> &#8594; A, and Y<sup>698</sup> &#8594; A mutations.</p>
###xml 1642 2702 1618 2622 <fn xmlns:mml="http://www.w3.org/1998/Math/MathML" id="fn3"><label>1</label><p textid="14">Abbreviations: PS, <sc>l</sc>-&#945;-phosphatidylserine; PC, <sc>l</sc>-&#945;-phosphatidylcholine; PCPS, small unilamellar phospholipid vesicles composed of 75% PC and 25% PS (w/w); SDS-PAGE, sodium dodecyl sulfate&#8722;polyacryl-amide gel electrophoresis; PVDF, polyvinylidene difluoride; factor Va<sup>Wt</sup>, recombinant human wild-type factor Va; factor Va<sup>KF</sup>, recombinant human factor Va with the D<sup>334</sup> &#8594; K and Y<sup>335</sup> &#8594; F mutations; factor Va<sup>AA</sup>, recombinant human factor Va with the D<sup>334</sup> &#8594; A and Y<sup>335</sup> &#8594; A mutations; factor V<sup>KFKF</sup>, recombinant human factor V with the <sup>695</sup>DYDY<sup>698</sup> &#8594; KFKF mutation; factor V<sup>4A</sup>, recombinant human factor V with the <sup>695</sup>DYDY<sup>698</sup> &#8594; AAAA mutation; factor Va<sup>3K</sup>, recombinant human factor Va with the D<sup>334</sup> &#8594; K, Y<sup>335</sup> &#8594; F, D<sup>695</sup> &#8594; K, Y<sup>696</sup> &#8594; F, D<sup>697</sup> &#8594; K, and Y<sup>698</sup> &#8594; F mutations; factor Va<sup>6A</sup>, recombinant human factor Va with the D<sup>334</sup> &#8594; A, Y<sup>335</sup> &#8594; A, D<sup>695</sup> &#8594; A, Y<sup>696</sup> &#8594; A, D<sup>697</sup> &#8594; A, and Y<sup>698</sup> &#8594; A mutations; factor V<sup>KF/4A</sup>, recombinant human factor Va with the D<sup>334</sup> &#8594; K, Y<sup>335</sup> &#8594; F, D<sup>695</sup> &#8594; A, Y<sup>696</sup> &#8594; A, D<sup>697</sup> &#8594; A, and Y<sup>698</sup> &#8594; A mutations.</p></fn>
###xml 332 337 <span type="species:ncbi:10090">mouse</span>
###xml 347 352 <span type="species:ncbi:9940">sheep</span>
###xml 965 970 <span type="species:ncbi:9606">human</span>
###xml 982 987 <span type="species:ncbi:9606">human</span>
###xml 1008 1013 <span type="species:ncbi:9606">human</span>
###xml 1422 1427 <span type="species:ncbi:9606">Human</span>
###xml 1934 1939 <span type="species:ncbi:9606">human</span>
###xml 1986 1991 <span type="species:ncbi:9606">human</span>
###xml 2073 2078 <span type="species:ncbi:9606">human</span>
###xml 2161 2166 <span type="species:ncbi:9606">human</span>
###xml 2239 2244 <span type="species:ncbi:9606">human</span>
###xml 2318 2323 <span type="species:ncbi:9606">human</span>
###xml 2454 2459 <span type="species:ncbi:9606">human</span>
###xml 2592 2597 <span type="species:ncbi:9606">human</span>
Diisopropyl fluorophosphate (DFP), O-phenylenediamine (OPD) dihydrochloride, N-(2-hydroxyethyl)piperazine-N'-2-ethanesulfonic acid (Hepes), Trizma (Tris base), and Coomassie Brilliant Blue R-250 were purchased from Sigma (St. Louis, MO). Factor V-deficient plasma was from Research Protein Inc. (Essex Junction, VT). Secondary anti-mouse and anti-sheep IgG coupled to peroxidase were purchased from Southern Biotechnology Associates Inc. (Birmingham, AL). l-alpha-Phosphatidylserine (PS)1 and l-alpha-phosphatidylcholine (PC) were from Avanti Polar Lipids (Alabaster, AL). Chemiluminescent reagent ECL+ and Heparin-Sepharose were from AmershamPharmacia Biotech Inc. (Piscataway, NJ). Normal reference plasma and chromogenic substrate Spectrozyme-TH were from American Diagnostica Inc. (Greenwich, CT). RecombiPlasTin for the clotting assays was purchased from Instrumentation Laboratory Co. (Lexington, MA). Dansylarginine-N-(3-ethyl-1,5-pentanediyl) amide (DAPA), human factor Xa, human alpha-thrombin, and human prothrombin were purchased from Haematologic Technologies Inc. (Essex Junction, VT). Factor V cDNA was from American Type Tissue Collection (Manassas, VA) (ATCC catalog no. 40515 pMT2-V). All restriction enzymes were from New England Biolabs (Beverly, MA). All molecular biology and tissue culture reagents, specific primers, and medium were from Gibco, Invitrogen Corp. (Grand Island, NY), or as indicated. Human factor V monoclonal antibodies (alphaHFVHC17 and alphaHFVLC9) and monoclonal antibody alphaHFV1 coupled to Sepharose were provided by K. G. Mann (Department of Biochemistry, University of Vermont, Burlington, VT). 1Abbreviations: PS, l-alpha-phosphatidylserine; PC, l-alpha-phosphatidylcholine; PCPS, small unilamellar phospholipid vesicles composed of 75% PC and 25% PS (w/w); SDS-PAGE, sodium dodecyl sulfate-polyacryl-amide gel electrophoresis; PVDF, polyvinylidene difluoride; factor VaWt, recombinant human wild-type factor Va; factor VaKF, recombinant human factor Va with the D334 --> K and Y335 --> F mutations; factor VaAA, recombinant human factor Va with the D334 --> A and Y335 --> A mutations; factor VKFKF, recombinant human factor V with the 695DYDY698 --> KFKF mutation; factor V4A, recombinant human factor V with the 695DYDY698 --> AAAA mutation; factor Va3K, recombinant human factor Va with the D334 --> K, Y335 --> F, D695 --> K, Y696 --> F, D697 --> K, and Y698 --> F mutations; factor Va6A, recombinant human factor Va with the D334 --> A, Y335 --> A, D695 --> A, Y696 --> A, D697 --> A, and Y698 --> A mutations; factor VKF/4A, recombinant human factor Va with the D334 --> K, Y335 --> F, D695 --> A, Y696 --> A, D697 --> A, and Y698 --> A mutations.
###end p 13
###begin p 14
###xml 19 20 19 20 <sc xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 51 52 47 48 <sc xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 275 277 267 269 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt</sup>
###xml 327 329 319 321 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 369 372 361 364 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 384 387 374 377 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 414 416 402 404 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 456 459 444 447 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 471 474 457 460 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 500 504 484 488 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KFKF</sup>
###xml 542 545 526 529 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sup>
###xml 549 552 533 536 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">698</sup>
###xml 580 582 562 564 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">4A</sup>
###xml 620 623 602 605 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sup>
###xml 627 630 609 612 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">698</sup>
###xml 659 661 639 641 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 701 704 681 684 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 713 716 691 694 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 725 728 701 704 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sup>
###xml 737 740 711 714 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">696</sup>
###xml 749 752 721 724 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">697</sup>
###xml 765 768 735 738 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">698</sup>
###xml 795 797 763 765 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">6A</sup>
###xml 837 840 805 808 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 849 852 815 818 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 861 864 825 828 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sup>
###xml 873 876 835 838 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">696</sup>
###xml 885 888 845 848 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">697</sup>
###xml 901 904 859 862 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">698</sup>
###xml 930 935 886 891 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF/4A</sup>
###xml 975 978 931 934 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 987 990 941 944 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 999 1002 951 954 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sup>
###xml 1011 1014 961 964 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">696</sup>
###xml 1023 1026 971 974 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">697</sup>
###xml 1039 1042 985 988 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">698</sup>
###xml 291 296 <span type="species:ncbi:9606">human</span>
###xml 343 348 <span type="species:ncbi:9606">human</span>
###xml 430 435 <span type="species:ncbi:9606">human</span>
###xml 518 523 <span type="species:ncbi:9606">human</span>
###xml 596 601 <span type="species:ncbi:9606">human</span>
###xml 675 680 <span type="species:ncbi:9606">human</span>
###xml 811 816 <span type="species:ncbi:9606">human</span>
###xml 949 954 <span type="species:ncbi:9606">human</span>
Abbreviations: PS, l-alpha-phosphatidylserine; PC, l-alpha-phosphatidylcholine; PCPS, small unilamellar phospholipid vesicles composed of 75% PC and 25% PS (w/w); SDS-PAGE, sodium dodecyl sulfate-polyacryl-amide gel electrophoresis; PVDF, polyvinylidene difluoride; factor VaWt, recombinant human wild-type factor Va; factor VaKF, recombinant human factor Va with the D334 --> K and Y335 --> F mutations; factor VaAA, recombinant human factor Va with the D334 --> A and Y335 --> A mutations; factor VKFKF, recombinant human factor V with the 695DYDY698 --> KFKF mutation; factor V4A, recombinant human factor V with the 695DYDY698 --> AAAA mutation; factor Va3K, recombinant human factor Va with the D334 --> K, Y335 --> F, D695 --> K, Y696 --> F, D697 --> K, and Y698 --> F mutations; factor Va6A, recombinant human factor Va with the D334 --> A, Y335 --> A, D695 --> A, Y696 --> A, D697 --> A, and Y698 --> A mutations; factor VKF/4A, recombinant human factor Va with the D334 --> K, Y335 --> F, D695 --> A, Y696 --> A, D697 --> A, and Y698 --> A mutations.
###end p 14
###begin title 15
Construction of Recombinant Factor V Molecules
###end title 15
###begin p 16
###xml 8 12 8 12 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KFKF</sup>
###xml 25 27 25 27 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">4A</sup>
###xml 88 90 88 90 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref19">19</xref>
###xml 91 93 91 93 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref21">21</xref>
###xml 161 163 161 163 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 173 178 173 178 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF/4A</sup>
###xml 192 194 192 194 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">6A</sup>
###xml 285 287 285 287 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 345 346 345 346 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 345 346 345 346 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>A</bold></underline>
###xml 347 348 347 348 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 347 348 347 348 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>G</bold></underline>
###xml 349 350 349 350 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">T</bold>
###xml 349 350 349 350 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>T</bold></underline>
###xml 393 394 393 394 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 393 394 393 394 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>A</bold></underline>
###xml 396 397 396 397 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 396 397 396 397 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>C</bold></underline>
###xml 398 399 398 399 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">T</bold>
###xml 398 399 398 399 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>T</bold></underline>
###xml 440 443 440 443 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 445 448 445 448 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 482 486 480 484 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KFKF</sup>
###xml 555 557 553 555 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref19">19</xref>
###xml 581 586 579 584 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF/4A</sup>
###xml 629 631 627 629 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">4A</sup>
###xml 631 633 629 631 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref21">21</xref>
###xml 631 633 629 631 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="ref21">21</xref></sup>
###xml 679 681 677 679 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">6A</sup>
###xml 739 740 737 738 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 739 740 737 738 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>C</bold></underline>
###xml 742 745 740 743 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">GCC</bold>
###xml 742 745 740 743 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>GCC</bold></underline>
###xml 798 801 796 799 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">GGC</bold>
###xml 798 801 796 799 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>GGC</bold></underline>
###xml 803 804 801 802 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 803 804 801 802 <underline xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold>G</bold></underline>
###xml 853 855 851 853 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">4A</sup>
###xml 855 857 853 855 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref21">21</xref>
###xml 855 857 853 855 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="ref21">21</xref></sup>
Factor VKFKF and factor V4A were constructed as previously described by our laboratory (19,21). Recombinant factor V molecules with combining mutations, factor V3K, factor VKF/4A, and factor V6A, were constructed using Stratagene's QuikChange XL site-directed mutagenesis kit. Factor V3K was constructed using the mutagenic primers 5'-C ATT TGG AAGTTT GCA CCT G-3' (forward) and 5'-C AGG TGC AAA CTTCCA AAT G-3' (reverse) (corresponding to 334DY335 --> KF mutations), using factor VKFKF as a template (bold underlined letters identify the mutated bases) (19). To construct factor VKF/4A, these same primers were used and factor V4A21 was used as the template in the PCR. Factor V6A was constructed with the primers 5'-GAG GAA GTC ATT TGG GCC GCC GCA CCT GTA ATA-3' (forward) and 5'-TAT TAC AGG TGC GGC GGC CCA AAT GAC TTC CTC-3' (reverse), with factor V4A21 as the template in the PCR. The mutations were confirmed by DNA sequencing (DNA Analysis Facility, Cleveland State University).
###end p 16
###begin title 17
Transient Transfection, Purification, and Assay of Recombinant Factor V Molecules
###end title 17
###begin p 18
###xml 37 39 37 39 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt</sup>
###xml 50 52 50 52 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 62 67 62 67 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF/4A</sup>
###xml 81 83 81 83 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">6A</sup>
###xml 256 258 256 258 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref17">17</xref>
###xml 259 261 259 261 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref24">24</xref>
###xml 399 401 395 397 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref25">25</xref>
###xml 733 735 723 725 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref26">26</xref>
###xml 736 738 726 728 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref27">27</xref>
###xml 1260 1262 1238 1240 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref17">17</xref>
###xml 1266 1268 1244 1246 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref24">24</xref>
###xml 1272 1274 1250 1252 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref25">25</xref>
###xml 1282 1284 1260 1262 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref28">28</xref>
Purified wild-type factor V (factor VWt), factor V3K, factor VKF/4A, and factor V6A plasmids were transfected into the COS-7L cells with fugene 6 (Roche Diagnostics), according to the manufacturer's instructions as described extensively by our laboratory (17,24). The recombinant proteins were purified on a 2 mL column of monoclonal antibody alphahFV1 coupled to Sepharose as described previously (25). The purified proteins were stored at -80 degreesC in small aliquots to avoid repeated freeze-thaw cycles. The activity and the integrity of the recombinant factor V molecules were confirmed by clotting assays using factor V-deficient plasma and Western blotting with monoclonal and polyclonal antibodies as described previously (26,27). Following activation of factor V, alpha-thrombin was inhibited by the addition of DFP. It is also important to note that any residual alpha-thrombin activity that could contribute to our experimental data is eliminated by the addition of DAPA to the reaction mixtures. DAPA is a very potent synthetic inhibitor of alpha-thrombin and eliminates any feedback activity that would interfere in experiments presented herein. A detailed description of all details relating to our experimental procedures is provided in refs (17), (24), (25), and (28).
###end p 18
###begin title 19
Gel Electrophoresis and Western Blotting
###end title 19
###begin p 20
###xml 382 384 379 381 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref29">29</xref>
###xml 534 536 531 533 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref30">30</xref>
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analyses were carried out using 4 to 12% gradient gels or 9.5% gels following reduction with 2% beta-mercaptoethanol, according to the method of Laemmli, and the protein was visualized by being stained with Coomassie Brilliant Blue R-250, followed by destaining in a solution of methanol, acetic acid, and water (29). In several experiments, the protein was transferred to polyvinylidene difluoride (PVDF) membranes following the method described by Towbin et al. (30). Factor Va heavy and light chains were probed with the appropriate monoclonal and polyclonal antibodies and visualized with chemiluminescence.
###end p 20
###begin title 21
Kinetic Titrations of Prothrombinase
###end title 21
###begin p 22
###xml 184 186 184 186 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref24">24</xref>
###xml 432 433 426 427 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 502 503 496 497 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 503 504 497 498 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">D</sub>
###xml 792 793 786 787 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 793 794 787 788 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 799 800 793 794 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 800 803 794 797 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 1491 1493 1473 1475 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
###xml 1494 1496 1476 1478 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref24">24</xref>
The ability of the recombinant factor V molecules to assemble in the prothrombinase complex and bind to the enzyme was assessed in a discontinuous assay described in detail elsewhere (24). All recombinant factor V molecules were activated with alpha-thrombin, and reaction mixtures contained PCPS vesicles (20 muM), DAPA (3 muM), and factor Xa (varying concentrations), in reaction buffer consisting of HEPES, 0.15 M NaCl, 5 mM CaCl2, and 0.01% Tween 20 (pH 7.40). For the practical calculation of the KD between the factor Va molecules and factor Xa, assays were performed in the presence of a limiting factor Xa concentration (15 pM) and varying concentrations of the recombinant factor Va species (25 pM to 5 nM). For the determination of the kinetic constants of prothrombinase function (Km and kcat), experiments were conducted with a limiting amount of factor Xa (5 pM) in the presence of a fixed saturating amount of the various recombinant factor Va molecules (10-30 nM) and varying the substrate concentration. The rate of alpha-thrombin generation was measured using a chromogenic substrate, Spectrozyme TH, which probes for alpha-thrombin generation. The initial rate of alpha-thrombin generation was analyzed with Prizm (GraphPad). The change in transition-state stabilization free energy, which measures the effect of the mutations in the cofactor on the catalytic site of the enzyme, was calculated for the double mutants as extensively described previously by our laboratory (23,24).
###end p 22
###begin title 23
Studies of the Pathway for Prothrombin Activation by Gel Electrophoresis
###end title 23
###begin p 24
###xml 124 126 122 124 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt</sup>
###xml 137 139 135 137 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 150 155 148 153 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF/4A</sup>
###xml 170 172 168 170 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">6A</sup>
###xml 229 231 223 225 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 435 437 429 431 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref20">20</xref>
###xml 438 440 432 434 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref24">24</xref>
###xml 525 527 519 521 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref20">20</xref>
Prothrombin was incubated in a reaction mixture containing 20 muM PCPS, 50 muM DAPA, and various concentrations of factor VaWt, factor Va3K, factor VaKF/4A, and factor Va6A (activated with alpha-thrombin, 10-30 nM) in TBS with Ca2+. A zero point was taken, and the addition of factor Xa (1 nM) marked the start of the reaction. Aliquots of the reaction mixture were removed at selected time points and treated as described previously (20,24). Calculations of the rates of prothrombin consumption were performed as described (20).
###end p 24
###begin title 25
Molecular Dynamics Simulations
###end title 25
###begin p 26
###xml 47 49 47 49 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref15">15</xref>
###xml 192 194 192 194 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref31">31</xref>
###xml 221 223 221 223 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 226 229 226 229 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 238 241 236 239 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 250 253 246 249 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sup>
###xml 262 265 256 259 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">696</sup>
###xml 274 277 266 269 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">697</sup>
###xml 286 289 276 279 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">698</sup>
###xml 384 386 372 374 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref32">32</xref>
###xml 628 631 616 619 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 633 636 621 624 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 645 647 633 635 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
The amino acid changes in the factor Va model (15) were introduced using SwissPdbViewer. Amino acid side chain orientation was selected using the rotamer library provided with SwissPdbViewer (31). The new model [factor Va3K (D334 --> K, Y335 --> F, D695 --> K, Y696 --> F, D697 --> K, Y698 --> F)] was solvated in a simulation box using the SPC water model using the GROMACS package (32). The minimum distance between the periodic images of the molecule was set to 1 nm. The simulation time was set to 3 ns. Simulation details were kept the same as recently described for the study of factor Va molecules with mutations in the D334-Y335 region (23). The simulation equilibrated after 2 ns, and the last nanosecond was used for analysis. Equilibration of the system was also assessed on the basis of the negligible drift of several parameters such as the potential energy, pressure, and temperature.
###end p 26
###begin title 27
Results
###end title 27
###begin title 28
Transient Expression and Activation of Recombinant Factor V Molecules
###end title 28
###begin p 29
###xml 210 212 210 212 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref21">21</xref>
###xml 213 215 213 215 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
###xml 225 226 225 226 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">1</xref>
###xml 282 284 282 284 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 341 346 341 346 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF/4A</sup>
###xml 407 409 407 409 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">6A</sup>
###xml 465 466 465 466 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">1</xref>
###xml 489 491 489 491 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt</sup>
###xml 604 606 604 606 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref25">25</xref>
###xml 616 617 616 617 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">2</xref>
###xml 687 689 687 689 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 1036 1037 1032 1033 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">2</xref>
###xml 1196 1197 1192 1193 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">2</xref>
###xml 1244 1249 1240 1245 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF/4A</sup>
###xml 1262 1264 1258 1260 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">6A</sup>
To assess the importance of amino acid regions 334-335 and 695-698 from the heavy chain of factor Va, we constructed molecules that combine mutations in these previously identified "hot spots" of the molecule (21,23) (Figure 1). We prepared recombinant factor Va molecules, factor V3K (D334K, Y334F, D695K, Y696F, D697K, and Y698F), factor VKF/4A (D334K, Y335F, D695A, Y696A, D697A, and Y698A), and factor V6A (D334A, Y335A, D695A, Y696A, D697A, and D698A) (Figure 1). Recombinant factor VWt and the mutant molecules were expressed in mammalian cells and purified to homogeneity as described previously (25). Figure 2 illustrates a typical quality control procedure highlighting factor V3K. Following activation by alpha-thrombin, SDS-PAGE analyses followed by immunoblotting with specific monoclonal antibodies to the heavy and light chain of the cofactor demonstrate that the mutant recombinant protein is intact, homogeneous, and composed of heavy and light chains that migrated according to their expected molecular weights (Figure 2A). In addition, control experiments using a polyclonal antibody to factor V demonstrate that all factor V molecules were fully activated prior to use (Figure 2B). Similar results were obtained with factor VKF/4A and factor V6A.
###end p 29
###begin p 30
###xml 71 73 71 73 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 87 89 87 89 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt</sup>
###xml 102 104 102 104 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 156 156 152 152 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec2"/>
###xml 297 299 289 291 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">HC</sub>
###xml 415 417 403 405 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">HC</sub>
###xml 462 464 450 452 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt</sup>
###xml 477 479 465 467 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
Electrophoretic analyses of wild-type factor V and recombinant factor V3K. (A) Factor VWt and factor V3K were activated with alpha-thrombin as described in  and analyzed by SDS-PAGE. Following transfer to a PVDF membrane, immunoreactive fragments were detected with monoclonal antibodies alphaHFVaHC17 (recognizing an epitope on the heavy chain of the cofactor between amino acid residues 307 and 506) and alphaHFVaHC9 (recognizing the light chain). (B) Factor VWt and factor V3K were activated with alpha-thrombin and analyzed by SDS-PAGE. Following transfer to a PVDF membrane, immunoreactive fragments were detected with a polyclonal antibody. In both cases, the immunoblot containing the mutant molecule was overexposed. At the right are shown the positions of the heavy and light chains of factor Va.
###end p 30
###begin p 31
###xml 133 135 129 131 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt</sup>
###xml 436 438 432 434 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">6A</sup>
###xml 507 512 503 508 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF/4A</sup>
###xml 596 598 592 594 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
The recombinant molecules were first assessed for their clotting activity in a two-stage assay. alpha-Thrombin activation of factor VWt resulted in a cofactor with clotting activity (2400 units/mg) similar to that of the plasma-derived molecule (2500 units/mg). Under similar experimental conditions, all mutant recombinant factor Va molecules displayed reduced clotting activities compared to the wild-type cofactor molecule. Factor Va6A had a 4-fold decrease in clotting activity (600 units/mg); factor VaKF/4A displayed a 6.3-fold reduction in clotting activity (380 units/mg), while factor Va3K was most impaired in its clotting activity with a 20-fold decrease (120 units/mg). These data demonstrate that the mutations are detrimental to factor Va clotting activity.
###end p 31
###begin title 32
Kinetic Analyses of Recombinant Factor Va Molecules
###end title 32
###begin p 33
###xml 379 380 375 376 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">3</xref>
###xml 391 392 387 388 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">1</xref>
###xml 519 521 515 517 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt</sup>
###xml 614 615 610 611 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">1</xref>
###xml 676 678 672 674 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 689 694 685 690 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF/4A</sup>
###xml 709 711 705 707 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">6A</sup>
###xml 1090 1091 1074 1075 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">1</xref>
###xml 1094 1096 1078 1080 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref21">21</xref>
###xml 1097 1099 1081 1083 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
We examined the ability of the recombinant factor Va molecules to bind factor Xa and assemble in prothrombinase using an assay employing purified reagents and a chromogenic substrate to probe for alpha-thrombin generation. The assay was performed under conditions of limiting factor Xa concentrations while the concentration of recombinant factor Va molecules was varied. Figure 3 and Table 1 show the results of the kinetic studies. The data demonstrate that under the experimental conditions that were used, factor VaWt has an affinity for the enzyme, factor Xa, similar to that of its plasma counterpart (Table 1). Conversely, the recombinant factor Va molecules, factor Va3K, factor VaKF/4A, and factor Va6A, were impaired in their ability to bind the enzyme, having dissociation constants approximately6-8-fold higher than that of the wild-type molecule. These results are surprising because when amino acid regions 334-335 and 695-698 are mutated separately, there is no significant effect on the dissociation constant of the recombinant molecules for plasma-derived factor Xa (Table 1) (21,23). These data suggest that the mutations destabilize the factor Va binding domain(s) for factor Xa.
###end p 33
###begin p 34
###xml 176 176 172 172 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec2"/>
###xml 271 273 267 269 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt</sup>
###xml 288 290 284 286 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 305 310 301 306 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF/4A</sup>
###xml 329 331 325 327 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">6A</sup>
###xml 764 764 756 756 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec2"/>
###xml 951 953 942 944 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt</sup>
###xml 968 970 959 961 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 985 990 976 981 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF/4A</sup>
###xml 1009 1011 1000 1002 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">6A</sup>
(A) Factor Va titrations to determine the affinity of the recombinant factor Va molecules for factor Xa. alpha-Thrombin generation experiments were carried out as described in . The prothrombinase complex was assembled with varying concentrations of recombinant factor VaWt (◼), factor Va3K (▲), factor VaKF/4A (▼), and factor Va6A (●). The solid lines represent a nonlinear regression fit of the data using GraphPad Prizm for a one-binding site model. Titrations were performed in triplicate with at least three different preparations of purified proteins. (B) Prothrombin titrations to determine the kinetic parameters of prothrombinase assembled with various recombinant factor Va species. alpha-Thrombin generation experiments were carried out as described in  by varying the substrate concentration (from 25 nM to 4 muM) with 5 pM factor Xa saturated with the factor Va species. The prothrombinase complex was assembled with recombinant factor VaWt (◼), factor Va3K (▲), factor VaKF/4A (▼), and factor Va6A (●). The solid lines represent the nonlinear regression fit of the data using GraphPad Prizm for the Michaelis-Menten equation. The data shown are the averages of five different titrations with different preparations of purified proteins.
###end p 34
###begin title 35
Functional Properties of Recombinant Factor Va Molecules
###end title 35
###begin p 36
###xml 87 88 87 88 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 88 92 88 92 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">Dapp</sub>
###xml 126 126 126 126 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec2"/>
###xml 201 202 201 202 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">3</xref>
Apparent dissociation constants of recombinant factor Va for plasma-derived factor Xa (KDapp) were determined as described in  at limiting factor Xa concentrations (the raw data are provided in Figure 3A).
###end p 36
###begin p 37
###xml 9 10 9 10 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 10 11 10 11 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 16 17 16 17 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 17 20 17 20 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 53 53 53 53 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec2"/>
###xml 178 179 178 179 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">3</xref>
Apparent Km and kcat were determined as described in  at limiting factor Xa concentrations (5 pM) and saturating concentrations of factor Va (the raw data are provided in Figure 3B).
###end p 37
###begin p 38
###xml 10 12 10 12 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref21">21</xref>
From ref (21).
###end p 38
###begin p 39
###xml 59 61 59 61 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
The recombinant molecules were fully characterized in ref (23).
###end p 39
###begin p 40
###xml 56 57 56 57 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 57 58 57 58 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 63 64 63 64 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 64 67 64 67 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 131 132 131 132 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">3</xref>
###xml 184 185 184 185 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">4</xref>
###xml 196 197 196 197 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">1</xref>
###xml 308 310 308 310 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt</sup>
###xml 423 424 423 424 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 424 428 424 428 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">Dapp</sub>
###xml 768 769 768 769 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">1</xref>
###xml 860 861 860 861 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 861 862 861 862 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 1082 1084 1082 1084 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt</sup>
###xml 1093 1094 1093 1094 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">4</xref>
###xml 1156 1158 1156 1158 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 1169 1174 1169 1174 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF/4A</sup>
###xml 1188 1190 1188 1190 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">6A</sup>
###xml 1337 1339 1337 1339 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt</sup>
###xml 1446 1450 1446 1450 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KFKF</sup>
###xml 1464 1466 1464 1466 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">4A</sup>
###xml 1580 1581 1580 1581 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">1</xref>
###xml 1593 1594 1593 1594 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">4</xref>
###xml 1717 1719 1717 1719 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref21">21</xref>
###xml 2013 2017 2013 2017 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KFKF</sup>
###xml 2031 2033 2031 2033 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">4A</sup>
###xml 2127 2130 2127 2130 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">320</sup>
###xml 2375 2377 2375 2377 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt</sup>
###xml 2434 2436 2434 2436 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 2447 2452 2447 2452 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF/4A</sup>
###xml 2467 2469 2467 2469 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">6A</sup>
###xml 2533 2536 2533 2536 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">320</sup>
###xml 2544 2547 2544 2547 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">271</sup>
###xml 2944 2945 2940 2941 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 2945 2948 2941 2944 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 2949 2950 2945 2946 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 2950 2951 2946 2947 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 3076 3077 3072 3073 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">4</xref>
We further evaluated the effect of the mutations on the Km and kcat values of prothrombinase. The raw data are displayed in Figure 3B, and the kinetic constants are provided in Figure 4 and Table 1. Because we wanted to prevent the possibility that differences between prothrombinase assembled with factor VaWt and prothrombinase assembled with the factor Va mutant molecules may be attributed to subtle differences in the KDapp of factor Va for factor Xa, which would result in a smaller amount of prothrombinase formed, all experiments described below were conducted under conditions where more than 95% of factor Xa was saturated with factor Va. Calculations were performed using the dissociation constants of all recombinant molecules for factor Xa shown in Table 1. Under the experimental conditions that were employed, the mutations had no effect on the Km of the reaction, while the catalytic efficiencies of prothrombinase assembled with the mutant recombinant cofactor molecules were decreased compared to the catalytic efficiency of prothrombinase assembled with factor VaWt (Figure 4A). The data show that prothrombinase assembled with factor Va3K, factor VaKF/4A, or factor Va6A had a 6-, 1.7-, or 1.3-fold reduced catalytic efficiency, respectively, compared to the value obtained for prothrombinase assembled with factor VaWt. Conversely, when amino acid region of residues 695-698 alone is mutated to either KFKF or AAAA, factor VaKFKF and factor Va4A have 1.2- and 1.4-fold increased catalytic efficiencies, respectively, compared to the wild-type molecule (Table 1 and Figure 4A). This increased catalytic efficiency can be explained by sustained meizothrombin accumulation as recently demonstrated (21). Indeed, when the ability of the recombinant factor Va molecules to be incorporated into prothrombinase and activate prothrombin was investigated by gel electrophoresis, persistence of meizothrombin was observed in the case of prothrombin activation by prothrombinase assembled with factor VaKFKF and factor Va4A as assessed by the lingering of fragment 1.2-A which is indicative of initial cleavage at Arg320 (not shown). However, prothrombinases assembled with the cofactor molecules bearing the combined mutations have a slower rate of prothrombin consumption compared to the rates of prothrombin consumption by prothrombinase assembled with factor VaWt, indicating that prothrombinase assembled with factor Va3K, factor VaKF/4A, and factor Va6A are impaired in their ability to cleave prothrombin at both Arg320 and Arg271. The inability of prothrombinase assembled with the three mutant cofactor molecules to function optimally can be explained by the inability of factor Xa to efficiently convert prothrombin to alpha-thrombin because of diminished productive collisions between the enzyme and prothrombin. Comparison of the second-order rate constant between prothrombinase assembled with the recombinant molecules (kcat/Km) demonstrates that the turnover number for prothrombinase assembled with the mutant molecules is 1.7-6-fold reduced (Figure 4B). Overall, the data demonstrate that amino acid regions 334-335 and 695-698 have important cooperative roles during prothrombin activation by prothrombinase.
###end p 40
###begin p 41
###xml 187 187 183 183 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec2"/>
###xml 239 240 235 236 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">3</xref>
###xml 248 249 244 245 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 249 250 245 246 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 296 297 292 293 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">1</xref>
###xml 309 310 305 306 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 310 313 306 309 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 338 340 334 336 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 394 396 390 392 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 398 400 394 396 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
Determination of the kinetic parameters of prothrombinase assembled with the various recombinant factor Va species. alpha-Thrombin generation experiments were carried out as described in  by varying the substrate concentration (see Figure 3B). The Km for all cofactor molecules is given in Table 1, while the kcat is shown in panel A (min-1). Panel B provides the second-order rate constants (M-1 s-1).
###end p 41
###begin title 42
Thermodynamic Effect of the Mutations in the Heavy Chain of Factor Va on Prothrombinase Function
###end title 42
###begin p 43
###xml 401 403 401 403 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt</sup>
###xml 417 419 415 417 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 548 549 538 539 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 549 550 539 540 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">&#10727;</sup>
###xml 550 557 540 545 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt&#8594;3K</sub>
###xml 595 596 571 572 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sch1" ref-type="scheme">1</xref>
###xml 743 746 719 722 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 748 751 724 727 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 756 759 732 735 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sup>
###xml 763 766 739 742 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">698</sup>
###xml 946 947 922 923 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sch1" ref-type="scheme">1</xref>
###xml 958 960 934 936 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 977 978 945 946 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 978 981 946 949 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sub>
###xml 1171 1174 1137 1140 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 1176 1179 1142 1145 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 1242 1244 1206 1208 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
###xml 1410 1414 1374 1378 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KFKF</sup>
###xml 1423 1424 1387 1388 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">4</xref>
###xml 1499 1504 1463 1468 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF/4A</sup>
###xml 1518 1520 1482 1484 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">6A</sup>
###xml 1910 1912 1874 1876 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
###xml 2060 2061 2024 2025 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 2061 2064 2025 2028 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 2106 2109 2070 2073 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">271</sup>
###xml 2144 2146 2108 2110 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref21">21</xref>
###xml 2269 2271 2229 2231 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 2326 2328 2286 2288 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt</sup>
Since prothrombinase is an enzyme composed of a catalytic subunit (factor Xa) and a regulatory subunit (factor Va), any perturbation in the interaction between the two proteins or any perturbations in the interaction of prothrombinase with the substrate caused by a mutation in the regulatory subunit may (will) influence the catalytic activity of factor Xa. The kinetic data showed that the factor VaWt --> factor Va3K transition results in a dramatic decrease in the catalytic efficiency of factor Va translated by a positive value for DeltaDeltaG⧧Wt-->3K of approximately1.1 kcal/mol (Scheme 1). To determine if the side chains of the amino acids that are part of the two separate sites on the heavy chain of factor Va under investigation (334DY335 and 695DYDY698) interact with each other to affect the catalytic efficiency of factor Xa, thermodynamic cycles were created and the exchange in free energy was calculated and is shown in Scheme 1. Factor Va3K has a DeltaDeltaGint value of +0.47 kcal/mol, indicating that the DY --> KF substitutions at amino acid regions 334-335 and 695-698 indeed have an additive effect. However, the severe detrimental effect of the 334DY335 --> KF substitution in the heavy chain for cofactor activity (23) is partially offset by the increased catalytic activity of meizothrombin that lingers following activation of prothrombin by prothrombinase assembled with factor VaKFKF (Figure 4B). Similar results were found with prothrombinase assembled with factor VaKF/4A and factor Va6A. However, substituting all amino acids with alanine had a less detrimental effect on factor Va cofactor activity than when charge reversal mutations were introduced. The data demonstrate a differential effect of the mutations depending on both their nature and their location. Mutations in region 334-335 alone are detrimental to the function of prothrombinase regardless of their nature (23), while mutations in the COOH-terminal portion of the heavy chain of the molecule alone are perceived as beneficial since they result in increased kcat values because of delayed cleavage at Arg271 and persistence of meizothrombin (21). We must thus conclude that the overall lower rate of alpha-thrombin formation by prothrombinase assembled with factor Va3K as compared to prothrombinase assembled with factor VaWt is the direct result of decreased productive collisions between enzyme and substrate. Thus, these six amino acid residues from the heavy chain of factor Va stabilize the interaction of factor Xa with the cofactor and appear to be directly involved in the activity of prothrombinase because they may be also responsible for the interaction with prothrombin.
###end p 43
###begin title 44
###xml 96 96 96 96 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sch1-fn1"/>
Thermodynamic Cycle for Prothrombinase Activity following Substitutions in Factor Va Heavy Chain
###end title 44
###begin p 45
###xml 10 11 2 3 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 11 14 3 6 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sub>
###xml 76 79 68 71 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 81 84 73 76 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 89 92 81 84 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sup>
###xml 96 99 88 91 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">698</sup>
###xml 169 171 161 163 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
###xml 234 235 218 219 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 235 236 219 220 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">&#10727;</sup>
###xml 515 516 491 492 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 516 517 492 493 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">&#10727;</sup>
###xml 517 524 493 498 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">WT&#8594;KF</sub>
###xml 539 540 505 506 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 540 541 506 507 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">&#10727;</sup>
###xml 541 548 507 512 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">WT&#8594;AA</sub>
###xml 565 567 529 531 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
DeltaDeltaGint is the free energy of interaction between the side chains of 334DY335 and 695DYDY698 of factor Va heavy chain and was calculated with eqs 3 and 4 of ref (23). The values illustrated on the arrows identify the DeltaDeltaG⧧ between recombinant species as indicated. Parallel arrows show the difference in catalytic efficiency between prothrombinase assembled with different mutant factor Va molecules. Different forms of prothrombinase are compared for their ability to activate prothrombin (DeltaDeltaG⧧WT-->KF and DeltaDeltaG⧧WT-->AA taken from ref (23)).
###end p 45
###begin title 46
Structural Consequences of the Mutations
###end title 46
###begin p 47
###xml 7 8 7 8 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">5</xref>
###xml 116 119 116 119 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 125 128 125 128 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 169 172 169 172 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sup>
###xml 174 177 174 177 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">698</sup>
###xml 241 244 237 240 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">528</sup>
###xml 246 249 242 245 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">538</sup>
###xml 266 268 262 264 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 334 335 330 331 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">5</xref>
###xml 407 409 399 401 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 547 550 539 542 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">528</sup>
###xml 552 555 544 547 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">538</sup>
###xml 649 651 625 627 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 792 794 756 758 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
Figure 5 was constructed using the final snapshot of the model taken at 3 ns. The figure shows amino acid residues D334 and Y335 as blue sticks and amino acid residues K695-F698 as red sticks. The alpha-helix structure of amino acid region S528-F538 of the factor Va3K molecule was found to be preserved during the simulation (Figure 5, red cartoon). The center of mass of the alpha-helix from the factor Va3K molecule is shifted by 6.8 A as compared with the same structure in the unmodified factor Va molecule. The closest distance between the S528-F538 alpha-helix and the 695-698 region was found to be approximately24 A in the case of factor Va3K as compared to approximately33 A in the case of unmodified factor Va. Such a small distance between these amino acid groups in the factor Va3K molecule is probably due to the stronger electrostatic interaction deriving from the charge reversal mutations (i.e., D --> K at positions 695 and 698).
###end p 47
###begin p 48
###xml 107 109 107 109 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 148 151 148 151 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 157 160 157 160 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 210 213 210 213 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sup>
###xml 216 219 216 219 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">696</sup>
###xml 222 225 222 225 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">697</sup>
###xml 232 235 232 235 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">698</sup>
###xml 296 299 296 299 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">528</sup>
###xml 301 304 301 304 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">538</sup>
###xml 414 417 407 410 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">321</sup>
###xml 419 422 412 415 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">331</sup>
###xml 428 431 421 424 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">365</sup>
###xml 433 436 426 429 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">369</sup>
###xml 476 479 469 472 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">400</sup>
###xml 481 484 474 477 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">420</sup>
###xml 532 535 525 528 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">362</sup>
###xml 541 544 534 537 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">538</sup>
###xml 573 576 566 569 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">412</sup>
###xml 603 606 596 599 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">534</sup>
###xml 612 615 605 608 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">364</sup>
###xml 643 646 636 639 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">323</sup>
###xml 629 633 <span type="species:ncbi:159033">lime</span>
Structural analysis of factor Va heavy chain. The figure illustrates the final snapshot (3 ns) of factor Va3K with the mutated amino acid residues K334 and F335 depicted as blue sticks and amino acid residues K695, F696, K697, and F698 as red sticks. The region encompassing amino acid residues S528-F538 (alpha-helix) is represented as a red cartoon. The antiparalel beta-sheet structures of amino acid residues R321-V331 and K365-T369 are colored yellow. Amino acid region R400-H420 is shown as cyan ribbons. Amino acid residues H362 and F538 are shown as green sticks. S412 is shown as cyan sticks. N534 and K364 are shown as lime sticks. E323 is shown as orange sticks.
###end p 48
###begin title 49
Discussion
###end title 49
###begin p 50
###xml 281 284 277 280 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 286 289 282 285 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 419 421 415 417 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
###xml 586 589 582 585 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sup>
###xml 593 596 589 592 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">698</sup>
###xml 751 754 747 750 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">271</sup>
###xml 754 756 750 752 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref20">20</xref>
###xml 757 759 753 755 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref21">21</xref>
###xml 754 759 750 755 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="ref20">20</xref>,<xref ref-type="bibr" rid="ref21">21</xref></sup>
###xml 1104 1106 1100 1102 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 1203 1205 1199 1201 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">6A</sup>
###xml 1404 1406 1400 1402 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 1419 1423 1415 1419 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KFKF</sup>
###xml 1444 1446 1440 1442 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
###xml 1534 1536 1530 1532 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 1632 1634 1628 1630 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">4A</sup>
###xml 1874 1876 1858 1860 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">6A</sup>
###xml 2114 2116 2094 2096 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref21">21</xref>
###xml 2266 2269 2246 2249 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">271</sup>
###xml 2269 2271 2249 2251 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref33">33</xref>
###xml 2272 2274 2252 2254 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref34">34</xref>
###xml 2269 2274 2249 2254 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="ref33">33</xref>,<xref ref-type="bibr" rid="ref34">34</xref></sup>
###xml 2492 2494 2472 2474 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref15">15</xref>
Our data demonstrate that amino acid region 334-335 together with amino acid region 695-698 of factor Va heavy chain work in concert for efficient conversion of prothrombin to alpha-thrombin by factor Xa within prothrombinase. We have recently demonstrated that amino acid region D334-Y335 is critical for optimum rearrangement of enzyme and substrate required for efficient catalysis of prothrombin by prothrombinase (23). Mutation of these residues results in a molecule that is impaired in its cofactor capabilities for prothrombin activation. We have also established that residues 695DYDY698 from the COOH terminus of factor Va heavy chain are involved in cofactor function and regulate the rate of meizothrombin cleavage by prothrombinase at Arg27120,21. The data presented here demonstrate that when all six residues are mutated simultaneously, there is a significant effect on cofactor activity. However, depending on the nature of amino acid substitutions and their location, the effect may be large (nearly 6-fold reduction in the catalytic efficiency of prothrombinase assembled with factor Va3K) or modest (1.7-fold reduction in the catalytic efficiency of prothrombinase made with factor Va6A). In contrast, substitution of the amino acids in the two regions separately results in an 8-fold activity decrease or a 1.2-fold activity increase for prothrombinase assembled with either factor VaKF or factor VaKFKF, respectively (ref (23) and data presented here). Interestingly, while prothrombinase assembled with factor VaAA is still severely impaired in its catalytic efficiency, prothrombinase assembled with factor Va4A has an approximately40% higher catalytic efficiency than prothrombinase assembled with the wild-type molecule. As a consequence, a less detrimental effect for prothrombin activation was observed with prothrombinase assembled with factor Va6A as demonstrated by our assay using a chromogenic substrate to assess alpha-thrombin generation. All these findings can explain the dramatic loss of clotting activity of the mutant cofactors because of sustained meizothrombin generation (21). Meizothrombin has poor clotting activity because it has not yet exposed ABE-II that is covered by fragment 2 which is released upon cleavage at Arg27133,34. Overall, the results support our early hypothesis that amino acid regions 334-335 and 695-698 are on the surface of factor Va heavy chain and act in concert for optimal cofactor effect during prothrombin activation (15).
###end p 50
###begin p 51
###xml 83 88 83 84 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sup>
###xml 237 239 233 235 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
###xml 327 330 323 326 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sup>
###xml 332 335 328 331 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">699</sup>
###xml 341 344 337 340 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 346 349 342 345 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 403 405 399 401 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt</sup>
###xml 462 465 458 461 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">334</sup>
###xml 467 470 463 466 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">335</sup>
###xml 476 479 472 475 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sup>
###xml 481 484 477 480 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">699</sup>
###xml 515 517 511 513 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref23">23</xref>
###xml 643 646 635 638 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">528</sup>
###xml 648 651 640 643 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">538</sup>
###xml 664 666 656 658 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 680 682 672 674 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</sup>
###xml 717 719 709 711 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 726 729 718 721 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">528</sup>
###xml 731 734 723 726 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">538</sup>
###xml 756 759 744 747 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">321</sup>
###xml 761 764 749 752 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">331</sup>
###xml 766 769 754 757 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">365</sup>
###xml 771 774 759 762 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">369</sup>
###xml 887 889 872 874 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 916 918 901 903 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KF</sup>
###xml 1055 1057 1040 1042 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
###xml 1153 1155 1138 1140 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">3K</sup>
We have recently reported that the distances between the centers of masses of the Calpha atoms between amino acids 334 and 335 and the extremities of the factor Xa binding site taken separately, one by one, did not significantly change (23). However, while distance analysis between the center of masses of amino acid regions D695-Q699 and D334-Y335 showed an approximate distance of 16.1 A in factor VaWt, a similar distance analysis between amino acid groups K334-F335 and D695-Q699 yielded a distance of 13.6 A (23). Our previous study also revealed that there was a significant difference in the alpha-helix motif encompassing the region S528-F538 in factor VaKF and factor VaAA. However, in the case of factor Va3K, the S528-F538 alpha-helix and the R321-V331/K365-T369 beta-sheet appear to be unaffected by the mutations. Although one would expect the immediate milieu of factor Va3K to be similar to factor VaKF in the region encompassing amino acids 334 and 335, it appears that because of the second set of mutations (in region 695-698) factor Va3K adopts a different conformation. Thus, although the secondary structures described in factor Va3K were not affected structurally, the general conformation of the molecule in that region changed significantly. These data suggest a rearrangement of amino acids belonging to both sites following amino acid substitution. These rearrangements are detrimental to cofactor activity as demonstrated by our kinetic experiments and the thermodynamic data. This, in turn, can be attributed to the impaired interaction between factor Va and factor Xa (illustrated by the decreased affinity of the mutant molecules for factor Xa).
###end p 51
###begin p 52
###xml 184 185 180 181 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref3">3</xref>
###xml 186 188 182 184 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref35">35</xref>
###xml 189 191 185 187 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref37">37</xref>
###xml 292 293 288 289 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref8">8</xref>
###xml 294 296 290 292 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref10">10</xref>
###xml 597 599 585 587 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref18">18</xref>
###xml 600 602 588 590 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref19">19</xref>
###xml 783 786 771 774 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">271</sup>
###xml 976 978 964 966 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref20">20</xref>
###xml 979 981 967 969 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref21">21</xref>
###xml 1230 1232 1218 1220 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref38">38</xref>
###xml 1476 1479 1464 1467 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">692</sup>
###xml 1531 1534 1519 1522 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">678</sup>
###xml 1582 1583 1570 1571 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 1583 1586 1571 1574 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 1737 1739 1725 1727 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt</sup>
###xml 1739 1741 1727 1729 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref38">38</xref>
###xml 1739 1741 1727 1729 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="ref38">38</xref></sup>
###xml 1843 1847 1831 1835 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">KFKF</sup>
###xml 1861 1863 1849 1851 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">4A</sup>
###xml 1900 1901 1888 1889 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 1901 1904 1889 1892 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 2018 2020 2006 2008 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt</sup>
###xml 2156 2158 2144 2146 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref18">18</xref>
###xml 2159 2161 2147 2149 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref39">39</xref>
###xml 2162 2164 2150 2152 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref41">41</xref>
###xml 2191 2193 2179 2181 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref21">21</xref>
###xml 2260 2263 2248 2251 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sup>
###xml 2267 2270 2255 2258 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">698</sup>
###xml 2350 2353 2338 2341 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">271</sup>
Earlier data have demonstrated that meizothrombin has increased catalytic efficiency toward chromogenic and fluorogenic substrates usually employed to assess alpha-thrombin formation (3,35-37) and that factor Va interacts with the substrate, prothrombin, via the heavy chain of the molecule (8,10). A synthetic peptide, representing amino acid residues 697-709 from the COOH terminus of the heavy chain of factor Va, was found to interact directly with alpha-thrombin-agarose, indicating that these amino acid residues of the cofactor provide a binding site for alpha-thrombin and/or prothrombin (18,19). Keeping all these findings in mind, we have recently established that the acidic COOH-terminal portion of factor Va heavy chain controls the rate of meizothrombin cleavage at Arg271 by factor Xa within prothrombinase, providing a productive interactive site of the cofactor with prothrombin, and thus contributes significantly to the enhanced function of prothrombinase (20,21). In contrast, Toso and Camire using recombinant proteins have reported that the acidic COOH-terminal region of factor Va heavy chain does not contribute to the increased catalytic activity of prothrombinase with respect to prothrombin activation (38). This conclusion was surprising and at odds with the data provided in their work since they show that prothrombinases assembled with recombinant cofactor molecules with deletions at the carboxy-terminal end of factor Va heavy chain, factor Va692 (missing amino acid residues 693-709) and factor Va678 (missing amino acid residues 679-709), display kcat values that are 1.3- and 1.5-fold increased, respectively, compared to the catalytic efficiency of prothrombinase assembled with recombinant factor VaWt38. Experiments provided here also demonstrate that prothrombinases assembled with recombinant factor VaKFKF and factor Va4A display 1.2- and 1.4-fold increased kcat values, respectively, compared to the catalytic efficiency of prothrombinase assembled with recombinant factor VaWt because of sustained meizothrombin formation during prothrombin activation. These results are in complete agreement with earlier data (18,39-41) and our recent findings (21), and the combined findings clearly demonstrate that the sequence 695DYDY698 controls meizothrombin concentration by controlling the rate of cleavage at Arg271 during prothrombin activation by prothrombinase.
###end p 52
###begin p 53
###xml 792 795 784 787 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">271</sup>
###xml 795 797 787 789 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref42">42</xref>
###xml 798 800 790 792 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref46">46</xref>
###xml 795 800 787 792 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="ref42">42</xref>&#8722;<xref ref-type="bibr" rid="ref46">46</xref></sup>
###xml 889 892 881 884 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML">271</sup>
###xml 1226 1228 1214 1216 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref33">33</xref>
###xml 1229 1231 1217 1219 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref47">47</xref>
###xml 1232 1234 1220 1222 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref52">52</xref>
###xml 1895 1897 1879 1881 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref28">28</xref>
###xml 2277 2279 2253 2255 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ref20">20</xref>
###xml 702 710 <span type="species:ncbi:9606">patients</span>
###xml 812 820 <span type="species:ncbi:9606">patients</span>
###xml 2123 2131 <span type="species:ncbi:9606">patients</span>
The bulk of the data published by our laboratory provide strong evidence pointing to the fact that the COOH-terminal acidic region of factor Va heavy chain and in particular amino acid sequence DYDY is crucial for efficient alpha-thrombin generation at the place of vascular injury. Bearing in mind the poor fibrinogen clotting properties of meizothrombin, we can hypothesize that following vascular injury, individuals with a factor Va molecule lacking the COOH-terminal region of the heavy chain will produce more meizothrombin, rather than alpha-thrombin, at the place of vascular injury, resulting in mild bleeding tendencies. This hypothetical situation is verified by clinical data obtained from patients that are homozygous for an amino acid substitution in the prothrombin gene at Arg27142-46. All these patients that have a prothrombin molecule that is unable to be cleaved at Arg271 circulating in their plasma were identified because of their hemorrhagic syndrome clinically resembling mild hemophilia. Thus, while meizothrombin can competently substitute for most of alpha-thrombin's procoagulant and anticoagulant functions locally at the place of vascular injury in the presence of an adequate membrane surface (33,47-52), the molecule still lacks the ultimate procoagulant function (i.e., efficient fibrin formation). All these observations together with the fact that prothrombin can be activated through two distinct pathways that differ in terms of rate constants and intermediates may allow for the design of novel anticoagulant molecules with the potential to act as a control switch and able to modulate specific events during alpha-thrombin (and meizothrombin) formation according to a precise need. DYDYQ may be the prototype for such a class of anticoagulants, and we have recently reported that DYDYQ inhibits prothrombin activation on the surface of endothelial cells (28), attesting to its physiological potency. Thus, if the requirement for anticoagulant therapy is to slow generation of alpha-thrombin activity without eliminating its production, thus generating a mild hemophilia phenotype in patients with thrombotic tendencies, a low concentration of DYDYQ will be enough to alleviate alpha-thrombin formation through the meizothrombin pathway (20). In contrast, if complete arrest of alpha-thrombin formation is required, higher concentrations of DYDYQ will completely eliminate alpha-thrombin generation through the prethrombin 2 pathway as well. In conclusion, pentapeptide DYDYQ provides an ideal backbone for exosite-directed anticoagulant molecules that could attenuate or fully suppress alpha-thrombin formation in individuals with thrombotic tendencies.
###end p 53
###begin title 54
Acknowledgement
###end title 54
###begin p 55
We thank Dr. Ken Mann and Dr. Tom Orfeo from the Department of Biochemistry at the University of Vermont for providing monoclonal antibodies to factor V.
###end p 55
###begin title 56
References
###end title 56
###begin article-title 57
The regulation of clotting factors.
###end article-title 57
###begin article-title 58
Factor V: A combination of Dr Jekyll and Mr Hyde.
###end article-title 58
###begin article-title 59
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 35 40 <span type="species:ncbi:9606">human</span>
Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism.
###end article-title 59
###begin article-title 60
Prothrombinase complex assembly. Contributions of protein-protein and protein-membrane interactions toward complex formation.
###end article-title 60
###begin article-title 61
The kinetics and cofactor dependence of the two cleavages involved in prothrombin activation.
###end article-title 61
###begin article-title 62
Loss of prothrombin and of factor Xa-factor Va interactions upon inactivation of factor Va by activated protein C.
###end article-title 62
###begin article-title 63
Interaction of clotting factor V heavy chain with prothrombin and prethrombin 1 and role of Activated Protein C in regulating this interaction: Analysis by analytical ultracentrifugation.
###end article-title 63
###begin article-title 64
The action of thrombin on blood clotting factor V: Conversion of factor V to a prothrombin-binding protein.
###end article-title 64
###begin article-title 65
Role of proexosite I in factor Va-dependent substrate interactions of prothrombin activation.
###end article-title 65
###begin article-title 66
###xml 67 72 <span type="species:ncbi:9606">human</span>
Demonstration of exosite I-dependent interactions of thrombin with human factor V and factor Va involving the factor Va heavy chain: Analysis by affinity chromatography employing a novel method for active-site-selective immobilization of serine proteinases.
###end article-title 66
###begin article-title 67
###xml 55 60 <span type="species:ncbi:9606">human</span>
Role of regulatory exosite I in binding of thrombin to human factor V, factor Va, factor Va subunits, and activation fragments.
###end article-title 67
###begin article-title 68
The subunit structure of thrombin-activated factor V. Isolation of activated factor V, separation of subunits, and reconstitution of biological activity.
###end article-title 68
###begin article-title 69
Characterization of Factor V activation intermediates.
###end article-title 69
###begin article-title 70
###xml 57 63 <span type="species:ncbi:9913">bovine</span>
The crystal structure of Activated Protein C-inactivated bovine factor Va: Implications for cofactor function.
###end article-title 70
###begin article-title 71
###xml 37 42 <span type="species:ncbi:9606">human</span>
Completed three-dimensional model of human coagulation factor Va. Molecular dynamics simulations and structural analyses.
###end article-title 71
###begin article-title 72
Identification of a binding site for blood coagulation factor Xa on the heavy chain of factor Va. Amino acid residues 323-331 of factor V represent an interactive site for activated factor X.
###end article-title 72
###begin article-title 73
Amino acids Glu323, Tyr324, Glu330, and Val331 of factor Va heavy chain are essential for expression of cofactor activity.
###end article-title 73
###begin article-title 74
Structural requirements for expression of factor Va activity.
###end article-title 74
###begin article-title 75
The contribution of amino acid region ASP695-TYR698 of factor V to procofactor activation and factor Va function.
###end article-title 75
###begin article-title 76
A control switch for prothrombinase: Characterization of a hirudin-like pentapeptide from the COOH terminus of factor Va heavy chain that regulates the rate and pathway for prothrombin activation.
###end article-title 76
###begin article-title 77
Role of the acidic hirudin-like COOH-terminal amino acid region of factor Va heavy chain in the enhanced function of prothrombinase.
###end article-title 77
###begin article-title 78
Posttranslational sulfation of factor V is required for efficient thrombin cleavage and activation and for full procoagulant activity.
###end article-title 78
###begin article-title 79
Contribution of Amino Acid Region 334-335 from Factor Va Heavy Chain to the Catalytic Efficiency of Prothrombinase.
###end article-title 79
###begin article-title 80
Incorporation of factor Va into prothrombinase is required for coordinated cleavage of prothrombin by factor Xa.
###end article-title 80
###begin article-title 81
Identification of an inactivating cleavage site for alpha-thrombin on the heavy chain of factor Va.
###end article-title 81
###begin article-title 82
Factor V.
###end article-title 82
###begin article-title 83
The contribution of amino acid residues 1508-1515 of factor V to light chain generation.
###end article-title 83
###begin article-title 84
The interaction of fragment 1 of prothrombin with the membrane surface is a prerequisite for optimum expression of factor Va cofactor activity within prothrombinase.
###end article-title 84
###begin article-title 85
###xml 67 83 <span type="species:ncbi:10665">bacteriophage T4</span>
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
###end article-title 85
###begin article-title 86
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications.
###end article-title 86
###begin article-title 87
SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling.
###end article-title 87
###begin article-title 88
Interaction models for water in relation to protein hydration. In
###end article-title 88
###begin article-title 89
###xml 37 42 <span type="species:ncbi:9606">human</span>
Characterization of a stable form of human meizothrombin derived from recombinant prothrombin (R155A, R271A, and R284A).
###end article-title 89
###begin article-title 90
###xml 107 113 <span type="species:ncbi:9913">bovine</span>
New insights into the regulation of the blood clotting cascade derived from the X-ray crystal structure of bovine meizothrombin des F1 in complex with PPACK.
###end article-title 90
###begin article-title 91
###xml 27 42 27 42 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">Echis carinatus</italic>
###xml 27 42 <span type="species:ncbi:40353">Echis carinatus</span>
Prothrombin activator from Echis carinatus venom.
###end article-title 91
###begin article-title 92
Meizothrombin: Active intemediate formed during prothrombin-catalyzed activation of prothrombin.
###end article-title 92
###begin article-title 93
Progressive development of a thrombin inhibitor binding site.
###end article-title 93
###begin article-title 94
Role of Hirudin-like factor Va heavy chain sequences in prothrombinase function.
###end article-title 94
###begin article-title 95
###xml 73 89 73 89 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">Naja naja oxiana</italic>
###xml 14 20 <span type="species:ncbi:9913">bovine</span>
###xml 73 89 <span type="species:ncbi:8657">Naja naja oxiana</span>
Activation of bovine factor V by an activator purified from the venom of Naja naja oxiana.
###end article-title 95
###begin article-title 96
###xml 25 30 <span type="species:ncbi:9606">human</span>
Functional properties of human factor Va lacking Asp683-Arg709 domain of the heavy chain.
###end article-title 96
###begin article-title 97
Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
###end article-title 97
###begin article-title 98
###xml 25 30 <span type="species:ncbi:9606">human</span>
Abnormal activation of a human prothrombin variant: Prothrombin Barcelona.
###end article-title 98
###begin article-title 99
Molecular defects of factor IX Chicago-2 (Arg 145-->His) and prothrombin Madrid (Arg 271-->Cys): Arginine mutations that preclude zymogen activation.
###end article-title 99
###begin article-title 100
Molecular defect of prothrombin Barcelona. Substitution of cysteine for arginine at residue 273.
###end article-title 100
###begin article-title 101
A point mutation (Arg271 to Cys) of a homozygote for dysfunctional prothrombin, prothrombin Obihiro, which has a region of high sequence variability.
###end article-title 101
###begin article-title 102
###xml 33 38 <span type="species:ncbi:9606">human</span>
Characterization of a variant of human prothrombin: Prothrombin Madrid.
###end article-title 102
###begin article-title 103
The structural integrity of anion binding exosite-I of thrombin is required and sufficient for timely cleavage and activation of factor V and factor VIII.
###end article-title 103
###begin article-title 104
The factor V activation paradox.
###end article-title 104
###begin article-title 105
###xml 14 19 <span type="species:ncbi:9606">human</span>
Activation of human factor V by meizothrombin.
###end article-title 105
###begin article-title 106
Multiple active forms of thrombin. Relative activities of meizothrombins.
###end article-title 106
###begin article-title 107
Expression of allosteric limkage between the sodium ion binding site and exosite I of thrombin during prothrombin activation.
###end article-title 107
###begin article-title 108
Protein C activation on endothelial cells by prothrombin activation products generated in situ: Meizothrombin is a better protein C activator than alpha-thrombin.
###end article-title 108

